Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The JointJYNT -0.71%63 EV-to-OCF is 24.71 as of Jul. 27, 2026, which is 14% below its 10-year median of 28.90. GuruFocus rates JYNT with a GF Score™ of 63/100 and a GF Value™ of $11.25 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, The Joint ranks worse than 83.31% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, The Joint's Enterprise Value is $100.42 Mil.
The Joint's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $4.06 Mil. Therefore, The Joint's EV-to-OCF for today is 24.71.
The historical rank and industry rank for The Joint's EV-to-OCF or its related term are showing as below:
JYNT'
s EV-to-OCF Range Over the Past 10 Years
Min: -1195.65 Med: 28.9 Max: 99.98
Current: 24.71
During the past 13 years, the highest EV-to-OCF of The Joint was 99.98. The lowest was -1195.65. And the median was 28.90.
JYNT's EV-to-OCF is ranked worse than 83.31% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.7
vs JYNT: 24.71
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Joint's share price for today is $8.35.
The Joint's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
The Joint EV-to-OCF Related Terms
The Joint EV-to-OCF Historical Data
* Premium members only.
The historical data trend for The Joint's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, The Joint's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where The Joint's EV-to-OCF falls into.
The Joint's current Enterprise Value is $100.42 Mil.
The Joint's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a EV-to-OCF of 24.71 as of Jul. 27, 2026. This is 14% below median its historical median of 28.90. According to the industry distribution chart, The Joint ranks #569 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 83.3%.
Is The Joint's EV-to-OCF too high?
The Joint's current EV-to-OCF of 24.71 is 14% below median its 10-year median of 28.90. The Healthcare Providers & Services industry median EV-to-OCF is 8.70. The Joint's value of 24.71 is 184% above this industry median. Based on the distribution chart, The Joint ranks #569 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, The Joint has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's EV-to-OCF compare to WW and PARK?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #569 out of 683 companies for EV-to-OCF. This places The Joint in the lower half of its industry. The industry median EV-to-OCF is 8.70. The Joint's value of 24.71 is 184% above this benchmark. While the company's 10-year median is 28.90 vs. the industry median of 8.70, The Joint has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.70, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current EV-to-OCF of 24.71 is 184% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current EV-to-OCF is 24.71, which is 14% below median its own 10-year median of 28.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.25, compared to a current price of $8.35 — trading 25.8% below its estimated fair value. The current EV-to-OCF is 24.71, which is 14% below median its 10-year median of 28.90 and 184% above the Healthcare Providers & Services industry median of 8.70. The Joint's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For The Joint (JYNT), the current EV-to-OCF is 24.71 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.35 is trading 25.8% below its estimated GF Value™ of $11.25.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
EV-to-OCF: 24.71 (14% below median its 10-year median of 28.90)
GF Value™: $11.25 vs. price of $8.35 (25.8% below fair value)
Industry Position: 184% above the Healthcare Providers & Services median (#569 of 683)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
63GF Score
Get the complete analysis for JYNT
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
